Cargando…
NICLOSAMIDE-EXFOLIATED ANIONIC CLAY NANOHYBRID REPURPOSED AS AN ANTIVIRAL DRUG FOR TACKLING COVID-19; ORAL FORMULATION WITH TWEEN 60/EUDRAGIT S100
The ongoing pandemic, COVID-19 (SARS-CoV-2), has afflicted millions of people around the world, necessitating that the scientific community work, diligently and promptly, on suitable medicaments. Although vaccination programs have been run globally, the new variants of COVID-19 make it difficult to...
Autores principales: | Rejinold, N. Sanoj, Piao, Huiyan, Choi, Goeun, Jin, Geun-Woo, Choy, Jin-Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584645/ https://www.ncbi.nlm.nih.gov/pubmed/34785820 http://dx.doi.org/10.1007/s42860-021-00153-6 |
Ejemplares similares
-
Injectable niclosamide nanohybrid as an anti-SARS-CoV-2 strategy
por: Rejinold, N. Sanoj, et al.
Publicado: (2021) -
Niclosamide–Clay Intercalate Coated with Nonionic Polymer for Enhanced Bioavailability toward COVID-19 Treatment
por: Yu, Seungjin, et al.
Publicado: (2021) -
Hydrotalcite–Niclosamide Nanohybrid as Oral Formulation towards SARS-CoV-2 Viral Infections
por: Choi, Goeun, et al.
Publicado: (2021) -
Bovine Serum Albumin-Coated Niclosamide-Zein Nanoparticles as Potential Injectable Medicine against COVID-19
por: Rejinold N, Sanoj, et al.
Publicado: (2021) -
Alendronate-Anionic Clay Nanohybrid for Enhanced Osteogenic Proliferation and Differentiation
por: Piao, Huiyan, et al.
Publicado: (2019)